Rockwell Medical, Inc. revised earnings guidance for the year 2024. For the year, the company now expects Net Sales to be $90.0 million to $94.0 million compared to prior guidance of net sales of $84.0 million to $88.0 million, 13% to 18% increase over $79.8 million in net product sales for 2023. Gross profit of $13.0 million to $15.0 million compared to prior guidance of Gross Profit of $12.0 million to $14.0 million, 49% to 72% increase over $8.7 million in gross profit for 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 USD | -1.10% | -0.56% | -5.29% |
14/05 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Earnings Flash (RMTI) ROCKWELL MEDICAL Reports Q1 Revenue $22.7M, vs. Street Est of $21.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.29% | 5.26Cr | |
+38.59% | 73TCr | |
-7.89% | 35TCr | |
+15.66% | 32TCr | |
+0.24% | 27TCr | |
+13.53% | 24TCr | |
+7.00% | 20TCr | |
-6.46% | 20TCr | |
+4.23% | 16TCr | |
-1.70% | 16TCr |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Revises Earnings Guidance for the Year 2024